Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
32 participants
INTERVENTIONAL
2018-01-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with high compound hyperopic astigmatism
eyes with ≥3.50 D hyperopia and ≥2.00 D of astigmatism undergoing planned surgery receiving a spherical Implantable Collamer Lens (ICL) followed by a planned adjunctive LASIK postoperatively
Implantable Collamer Lens (ICL) followed by a planned adjunctive LASIK postoperatively
Planned surgery to receive a spherical Implantable Collamer Lens (ICL) followed by a planned adjunctive LASIK postoperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implantable Collamer Lens (ICL) followed by a planned adjunctive LASIK postoperatively
Planned surgery to receive a spherical Implantable Collamer Lens (ICL) followed by a planned adjunctive LASIK postoperatively
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Astigmatism of ≥+2.00 D
* Stable refraction for the previous 12 months
* Age older or equal to 18 years
* Anterior chamber depth (ACD) from corneal endothelium to anterior lens capsule of 3.0 mm or greater
Exclusion Criteria
* Patients lost to follow-up
* Cataract formation
* History of glaucoma or retinal detachment
* Macular degeneration
* Diabetic retinopathy
* History of ocular inflammation
* Signifcant irregular corneal topography
* Evidence of inconsistent imaging from dry eyes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Li
Resident Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Avi Wallerstein, MD
Role: PRINCIPAL_INVESTIGATOR
McGill University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vision Group Canada
Montreal, , Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Li DQ, Gauvin M, Rocha G, Trottier P, Racine L, Wallerstein A. Spherical implantable collamer lens with postoperative adjunctive LASIK in the treatment of high compound hyperopic astigmatism. BMC Ophthalmol. 2025 Jan 24;25(1):44. doi: 10.1186/s12886-024-03828-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VGC81
Identifier Type: -
Identifier Source: org_study_id